Abstract
Background Cognition declines as age advances. Frailty is a pre-disability state. cognitive impairment and frailty lower the quality of life of elders. studies done in this background were mostly in urban or rural areas. Hence the current study was conducted among elders in the tribal areas to find the relationship between cognition and frailty.
Materials and methods It was a cross-sectional study done for a period of one year among 316 elders >60 years. Based on the reported prevalence of cognitive dysfunction among the elderly to be 25% (Rakesh M Patel et al), with 5% absolute allowable error,5% of alpha error, and 10% non-response rate) residing in the tribal areas of Mysuru. WHO-30 cluster sampling was used. MOCA-B was used for assessing cognition scale and the TFI scale was used for assessing frailty.
Results The prevalence of cognitive impairment and frailty was 95.3 % and 61.4% respectively. Factors like Gender, education, type of family, physical, financial and emotional dependency, and preference of treatment were associated with cognition. There was also a significant association between cognition and frailty.
Conclusion There was a higher prevalence of cognitive impairment among frail elders. Thus, early diagnosis and appropriate management are necessary for healthy ageing
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
The authors received no specific funding for this work.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
Institutional ethical committee JSS medical college,id:JSS/MC/PG/5156/2020-21
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Footnotes
email id-vanmathianbu09{at}gmail.com
email id: prakulfi{at}gmail.com
email id:dennis{at}svym.org.in
email id: sunilkumard{at}jssuni.edu.in
email id: ppatta08{at}gmail.com
email id: rkishormd{at}gmail.com
email id: dr.sayanabasheer{at}gmail.com
Data Availability
Data will be provided on request
